The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome – a randomized controlled study [ISRCTN35655335]

Christian von Heymann¹ , Michael Sander¹ , Achim Foer¹ , Anja Heinemann¹ , Bruce Spiess² , Jan Braun¹ , Michael Krämer¹ , Joachim Grosse¹ , Pascal Dohmen³ , Simon Dushe³ , Jürgen Halle³ , Wolfgang F Konertz³ , Klaus-Dieter Wernecke³ and Claudia Spies¹

¹Department of Anesthesiology and Intensive Care Medicine, Charité – University Hospital Berlin, Charité Campus Mitte, Berlin, Germany

²Department of Anesthesiology and the Virginia Commonwealth University Reanimation Engineering Shock Center (VCURES), Virginia Commonwealth University Medical Center, Richmond, Virginia, USA

³Department of Cardiovascular Surgery, Charité – University Hospital Berlin, Charité Campus Mitte, Berlin, Germany